1. Home
  2. CURR vs RCEL Comparison

CURR vs RCEL Comparison

Compare CURR & RCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Currenc Group Inc. Ordinary Shares

CURR

Currenc Group Inc. Ordinary Shares

HOLD

Current Price

$2.61

Market Cap

112.6M

ML Signal

HOLD

Logo Avita Medical Inc.

RCEL

Avita Medical Inc.

HOLD

Current Price

$4.03

Market Cap

132.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CURR
RCEL
Founded
2013
N/A
Country
Singapore
United States
Employees
N/A
226
Industry
Business Services
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
112.6M
132.0M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CURR
RCEL
Price
$2.61
$4.03
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
$7.88
AVG Volume (30 Days)
108.1K
214.9K
Earning Date
04-15-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$21.69
Revenue Next Year
$14.56
$49.58
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.33
$3.22
52 Week High
$4.68
$10.28

Technical Indicators

Market Signals
Indicator
CURR
RCEL
Relative Strength Index (RSI) 74.69 39.13
Support Level $1.44 $3.98
Resistance Level $4.68 $4.09
Average True Range (ATR) 0.14 0.29
MACD 0.02 -0.13
Stochastic Oscillator 92.86 12.60

Price Performance

Historical Comparison
CURR
RCEL

About CURR Currenc Group Inc. Ordinary Shares

Currenc Group Inc is a fintech pioneer dedicated to transforming financial services through artificial intelligence (AI). It empowers financial institutions with comprehensive AI solutions, including the SEAMLESS AI Call Centre and other AI-powered tools designed to reduce costs, increase efficiency, and boost customer satisfaction. The Company's digital remittance platform also enables e-wallets, remittance companies, and corporations to provide real-time, 24/7 payment services, advancing financial access across underserved communities. It generates the majority of its geographic revenue from Malaysia.

About RCEL Avita Medical Inc.

Avita is largely a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently used in most of the 140 US burn centers. Despite having product approval in Australia, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region, although international sales, particularly in Japan, are growing. Avita is domiciled, and has its primary listing, in the US.

Share on Social Networks: